Holista CollTech Ltd (ASX: HCT) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Holista CollTech Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $2.51 million
P/E Ratio N/A
Dividend Yield 0.00%
Shares Outstanding 278.80 million
Earnings per share -0.017
Dividend per share N/A
Year To Date Return -20.00%
Earnings Yield N/A
Franking -
Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

  • Holista CollTech Ltd (ASX: HCT)
    Latest News

    asx share penalty represented by lots of fingers pointing at disgraced businessman Crown royal commission WA
    Healthcare Shares

    ASIC accuses ASX company of misleading COVID-19 claims

    The chief executive of the WA business allegedly said on a YouTube video that its sanitiser spray can kill the…

    Read more »

    Speculative

    Why the Holista CollTech share price is climbing higher today

    The Holista CollTech Limited (ASX: HCT) share price is bucking the wider market sell-off today after the company announced the…

    Read more »

    Share Market News

    ASX stock of the day: This small-cap ASX wellness share jumped 6% today after it filed a global patent

    The share price of Holista CollTech Limited (ASX: HCT)has leapt 6% today after the company announced it had filed a…

    Read more »

    a woman
    Share Gainers

    These ASX shares are fighting the spread of coronavirus

    Some ASX shares are fighting coronavirus with demand for their products accelerating along with the spread of the virus. We…

    Read more »

    a woman
    ⏸️ Investing

    The Holista Colltech share price soars 170% today

    Holista Colltech Limited (ASX:HCT) announces major scientific breakthrough

    Read more »

    HCT ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About Holista CollTech Ltd

    Holista CollTech Ltd is a research-driven biotech company. Its operating segments include Supplements; Ovine Collagen; Infection Control Solutions; Food Ingredients; and Corporate. The supplements segment is involved in the manufacturing and wholesale distribution of dietary supplements. The ovine collagen segment is involved in the manufacturing and distribution of cosmetic grade collagen. The food ingredients segment is involved in the manufacturing and wholesale distribution of healthy food ingredients. The infection control segment is involved in the infection control solutions. The company generates a majority of its revenue from the Supplements segment. Geographically, it generates a majority of its revenue from Malaysia and the rest from Australia and the United States.

    HCT Share Price History Data provided by Morningstar.

    Data provided by Morningstar.
    Date Close Change % Change Volume Open High Low
    22 Jul 2024 $0.01 $0.00 0.00% 995,826 $0.01 $0.01 $0.01
    16 Jul 2024 $0.01 $0.00 0.00% 33,535 $0.01 $0.01 $0.01
    15 Jul 2024 $0.01 $0.00 0.00% 55,000 $0.01 $0.01 $0.01
    09 Jul 2024 $0.01 $0.00 0.00% 73,282 $0.01 $0.01 $0.01
    02 Jul 2024 $0.01 $0.00 0.00% 20,863 $0.01 $0.01 $0.01
    28 Jun 2024 $0.01 $0.00 0.00% 220,168 $0.01 $0.01 $0.01

    Directors & Management Data provided by Morningstar.

    Data provided by Morningstar.
    Name Title Start Date Profile
    Mr David Ross Deloub Non-Executive ChairmanNon-Executive Director Apr 2023
    Mr Deloub has over 30 years' experience in the finance and corporate sectors. He has held a number of executive positions including Chief Financial Officer at the ASX listed Neptune Marine Services and Executive Director at Patersons Capital Partners, a Perth based boutique advisory firm providing strategic and financial advice to ASX listed companies. David has considerable corporate finance, business development and financial market experience both in Australia the United States and Africa where he has held senior management positions at Alinta Energy Limited , Neptune Marine Services and Alcoa Inc in the US.
    Mrs Loren (Ann Jones) Anne King Non-Executive Director Jul 2021
    Mrs King has worked in corporate finance and senior administration roles with ASX listed companies, stockbroking and corporate advisory services for the past 18 years. During this time, she gained valuable experience in dealing with all aspects of corporate governance and compliance, specialising in initial public offerings (IPO), backdoor listings, private capital raising and business development.
    Mr Lai Kwok Kin Non-Executive Director Mar 2024
    Mr Lai is Founder and Managing Director of Singapore-based WeR1 Consultants Pte Ltd which provides counsel for investor relations and crisis communications to companies listed on regional exchanges.
    Mr Jay Richard Stephenson Company Secretary Sep 2021
    -
    Jay Richard Stephenson Company Secretary
    -

    Top Shareholders Data provided by Morningstar.

    Data provided by Morningstar.
    Name Shares Capital
    Galen Biomedical Inc 58,514,245 20.99%
    Bnp Paribas Nominees Pty Ltd <Ib Au Noms Retailclient> 36,305,083 13.02%
    818 Corporate Pty Ltd <818 A/C> 13,544,100 4.86%
    Ms Sarinderjit Kaur 9,675,785 3.47%
    Citicorp Nominees Pty Limited 8,201,949 2.94%
    Mr Robert Gemelli 7,915,016 2.84%
    Mr Anthony Robert Ramage 7,859,500 2.82%
    HSBC Custody Nominees (Australia) Limited 7,829,702 2.81%
    Fairview Holdings Pty Ltd <The Manjule Super A/C> 6,358,570 2.28%
    123 Home Loans Pty Ltd 5,300,000 1.90%
    Bnp Paribas Noms Pty Ltd Uobkh A/C R'Miers 4,258,201 1.53%
    Driscoll Future Pty Ltd <Driscoll Super Fund A/C> 3,750,000 1.35%
    Mr Himmat Singh 3,500,000 1.26%
    Chandra Sekaran P Perumal 3,333,333 1.20%
    Ide Super Pty Ltd <Ide Super Fund A/C> 3,005,221 1.08%
    Perpetual Capital Investments Pty Ltd 3,000,000 1.08%
    Jaz Future Fund Pty Ltd <Arr Superannuation Fund A/C> 2,515,500 0.90%
    Mrs Jalpaben Nileshkumar Shah 2,309,864 0.83%
    Hsbc Custody Nominees (Australia) Limited II 2,131,422 0.76%
    Mr Peter Klimis 1,876,029 0.67%

    Profile

    since

    Note